Drug Manufacturers General Stocks: Companies & Metrics

Browse 21 drug manufacturers general stocks with financial metrics and performance data (Healthcare sector).

Industry market cap: $4.37T
Cap-weighted, today: +2.01%
Cap-weighted, 1 year: +43.45%
Advancing / declining today: 15 / 5

Drug Manufacturers General Stocks

21 stocks in the drug manufacturers general industry. Click column headers to sort.

#
1	LLY	Eli Lilly and Company	$1,279.14	$1.14T	$79.67B	$26.71B	$29.79	2.31M
2	JNJ	Johnson & Johnson	$266.30	$652.06B	$99.33B	$21.04B	$8.63	7.28M
3	ABBV	AbbVie Inc.	$286.74	$507.82B	$64.39B	$6.31B	$3.56	4.84M
4	MRK	Merck & Co., Inc.	$140.61	$347.31B	$66.49B	$3.17B	$1.28	10.05M
5	NVS	Novartis AG	$153.81	$294.39B	$56.69B	$12.76B	$6.63	1.92M
6	AZN	AstraZeneca PLC	$172.06	$268.41B	$61.37B	$10.45B	$6.69	2.85M
7	AMGN	Amgen Inc.	$444.63	$241.88B	$38.09B	$8.74B	$16.09	2.94M
8	GILD	Gilead Sciences, Inc.	$158.69	$197.25B	$30.46B	-$3.24B	−$2.59	6.07M
9	NVO	Novo Nordisk A/S	$39.13	$173.57B	$49.22B	$17.40B	$3.91	12.83M
10	PFE	Pfizer Inc.	$29.79	$169.77B	$63.70B	$4.33B	$0.76	30.78M
11	BMY	Bristol-Myers Squibb Company	$61.61	$126.18B	$49.19B	$9.28B	$4.54	13.48M
12	GSK	GSK plc	$51.10	$103.78B	$44.27B	$6.43B	$3.15	4.94M
13	SNY	Sanofi	$41.79	$100.01B	$54.63B	$4.42B	$2.09	3.36M
14	BIIB	Biogen Inc.	$252.26	$37.51B	$10.03B	$835.09M	$5.65	1.25M
15	GRFS	Grifols, S.A.	$7.92	$5.39B	$8.32B	$544.28M	$0.87	662.51K
16	OGN	Organon & Co.	$13.74	$3.72B	$6.13B	$209.00M	$0.79	2.17M
17	AMRN	Amarin Corporation plc	$12.09	$251.74M	$186.16M	-$27.12M	−$1.30	61.50K
18	MDCX	Medicus Pharma Ltd.	$2.51	$138.19M	$0.00	-$39.15M	−$1.22	88.29K
19	NSRX	Nasus Pharma Ltd.	$3.49	$38.64M	$0.00	-$10.64M	−$1.11	22.67K
20	MIRA	MIRA Pharmaceuticals, Inc.	$0.53	$22.39M	$0.00	-$9.48M	−$0.30	146.44K
21	SCLX	Scilex Holding Company	$2.33	$16.06M	$31.61M	-$447.12M	−$55.36	41.80K

About the Drug Manufacturers General Industry

The Drug Manufacturers General industry includes 21 U.S.-listed companies in the Healthcare sector with a combined market capitalization of $4.37T. The largest are Eli Lilly and Company (LLY, $1.14T), Johnson & Johnson (JNJ, $652.06B) and AbbVie Inc. (ABBV, $507.82B), together 53% of the industry's value.

15 of the 21 companies with reported earnings are profitable, and their median P/E ratio is 25.7. 15 of 21 pay a dividend, with a median yield of 2.31% among payers.

Over the past year the median stock is up 23.3%, and 14 of 21 are higher than a year ago. Median revenue growth is 4.7% year over year.

Best 1-year performers

Weakest 1-year performers

Highest dividend yields

Profitability

Profitable companies: 15 of 21
Median gross margin: 72.1%
Median net profit margin: 9.1%
Median return on equity: 14.8%

Longest dividend growth streak: Johnson & Johnson (JNJ), 55 consecutive years.

Frequently Asked Questions About Drug Manufacturers General Stocks

How many stocks are in the drug manufacturers general industry?

There are 21 publicly traded stocks in the drug manufacturers general industry, part of the Healthcare sector.

Which drug manufacturers general stocks pay the highest dividend yields?

The highest yields in the drug manufacturers general industry are Sanofi (SNY, 5.77%), Pfizer Inc. (PFE, 5.65%) and Novo Nordisk A/S (NVO, 4.56%). Johnson & Johnson (JNJ) has the longest record of dividend increases, 55 consecutive years.

Which drug manufacturers general stocks performed best over the past year?

Over the past year the strongest drug manufacturers general stocks were AstraZeneca PLC (AZN, +106.9%), Biogen Inc. (BIIB, +69.1%) and Merck & Co., Inc. (MRK, +68.9%). The weakest were Novo Nordisk A/S (NVO, −25.9%), Grifols, S.A. (GRFS, −22.0%) and Sanofi (SNY, −15.3%).

Are drug manufacturers general companies profitable?

15 of the 21 drug manufacturers general companies with reported earnings are profitable, with a median gross margin of 72.1%, a median net profit margin of 9.1% and a median return on equity of 14.8%.